Bryan Wahl Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

Bryan Wahl is General Counsel of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 51,712 shares of TARS, which is worth approximately $2.56 Million. The most recent transaction as insider was on Mar 20, 2025, when has been sold 3,084 shares (Common Stock) at a price of $50.11 per share, resulting in proceeds of $154,539. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.7K

26.28% 3M change

26.28% 12M change

Total Value Held $2.56 Million

Bryan Wahl Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2025	SELL Open market or private sale	$154,539 $50.11 p/Share	3,084 Reduced 5.63%	51,712 Common Stock
Mar 19 2025	SELL Open market or private sale	$154,571 $47.4 p/Share	3,261 Reduced 5.62%	54,796 Common Stock
Mar 18 2025	SELL Open market or private sale	$154,654 $46.29 p/Share	3,341 Reduced 5.44%	58,057 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	19,213 Added 23.83%	61,398 Common Stock
Mar 18 2024	SELL Open market or private sale	$135,741 $30.6 p/Share	4,436 Reduced 9.77%	40,951 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	12,038 Added 20.96%	45,387 Common Stock
Nov 30 2023	SELL Open market or private sale	$136,286 $16.31 p/Share	8,356 Reduced 20.72%	31,966 Common Stock
Nov 29 2023	BUY Exercise of conversion of derivative security	-	23,920 Added 37.23%	40,322 Common Stock
Mar 23 2023	SELL Open market or private sale	$4,507 $12.15 p/Share	371 Reduced 2.21%	16,402 Common Stock
Mar 22 2023	SELL Open market or private sale	$4,512 $12.64 p/Share	357 Reduced 2.08%	16,773 Common Stock
Mar 21 2023	SELL Open market or private sale	$4,511 $12.89 p/Share	350 Reduced 2.0%	17,130 Common Stock
Mar 20 2023	SELL Open market or private sale	$4,501 $12.61 p/Share	357 Reduced 2.0%	17,480 Common Stock
Mar 17 2023	SELL Open market or private sale	$4,501 $13.28 p/Share	339 Reduced 1.87%	17,837 Common Stock
Mar 16 2023	SELL Open market or private sale	$4,525 $13.43 p/Share	337 Reduced 1.82%	18,176 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	-	4,790 Added 20.56%	18,513 Common Stock
Dec 02 2022	SELL Open market or private sale	$19,502 $16.9 p/Share	1,154 Reduced 7.76%	13,723 Common Stock
Dec 01 2022	SELL Open market or private sale	$19,497 $16.75 p/Share	1,164 Reduced 7.26%	14,877 Common Stock
Nov 30 2022	SELL Open market or private sale	$19,519 $16.5 p/Share	1,183 Reduced 6.87%	16,041 Common Stock
Nov 29 2022	BUY Exercise of conversion of derivative security	-	10,251 Added 37.31%	17,224 Common Stock

Bryan Wahl

General Counsel

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Value

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS

Account